2017
DOI: 10.1111/1755-0998.12734
|View full text |Cite
|
Sign up to set email alerts
|

Substantial differences in bias between single‐digest and double‐digest RAD‐seq libraries: A case study

Abstract: The trade-offs of using single-digest vs. double-digest restriction site-associated DNA sequencing (RAD-seq) protocols have been widely discussed. However, no direct empirical comparisons of the two methods have been conducted. Here, we sampled a single population of Gulf pipefish (Syngnathus scovelli) and genotyped 444 individuals using RAD-seq. Sixty individuals were subjected to single-digest RAD-seq (sdRAD-seq), and the remaining 384 individuals were genotyped using a double-digest RAD-seq (ddRAD-seq) prot… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
23
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 26 publications
(24 citation statements)
references
References 53 publications
1
23
0
Order By: Relevance
“…Some important issues when choosing software for parentage analysis for next‐generation markers, beyond whether they can analyse the type of parentage data collected (e.g., parent–offspring pairs, groups of putative siblings and putative parents, or parent–parent–offspring triads), are (a) whether the program can handle the number of markers used in the study and (b) whether the method can accept genotype likelihoods that reflect the genotype uncertainties characteristic of next‐generation sequencing or whether additional consideration of errors will be required. All of the methods worth mentioning incorporate error rates, but most of those error rates are based on expectations for microsatellites and will likely not properly incorporate error arising from sequencing errors, allelic dropout and PCR bias, all of which can dramatically impact genotypes in next‐generation sequencing data sets such as RAD‐seq data (Flanagan & Jones, ).…”
Section: Choosing Softwarementioning
confidence: 99%
See 1 more Smart Citation
“…Some important issues when choosing software for parentage analysis for next‐generation markers, beyond whether they can analyse the type of parentage data collected (e.g., parent–offspring pairs, groups of putative siblings and putative parents, or parent–parent–offspring triads), are (a) whether the program can handle the number of markers used in the study and (b) whether the method can accept genotype likelihoods that reflect the genotype uncertainties characteristic of next‐generation sequencing or whether additional consideration of errors will be required. All of the methods worth mentioning incorporate error rates, but most of those error rates are based on expectations for microsatellites and will likely not properly incorporate error arising from sequencing errors, allelic dropout and PCR bias, all of which can dramatically impact genotypes in next‐generation sequencing data sets such as RAD‐seq data (Flanagan & Jones, ).…”
Section: Choosing Softwarementioning
confidence: 99%
“…Rather, the advice is to remove loci suffering from null alleles or allelic dropout from the analysis, a solution that is relatively easy to apply to small microsatellite or SNP data sets but perhaps difficult to apply to the extremely large data sets produced by genotyping‐by‐sequencing approaches. In addition, the rate of allelic dropout may vary based on the type of next‐generation method used (Flanagan & Jones, ). Possible approaches are to use a program like gbstools to estimate which SNPs in the data set are most likely suffering from allelic dropout (Cooke et al, ) or to strictly filter loci for adherence to Hardy–Weinberg equilibrium.…”
Section: Avoiding Parentage Analysis Pitfallsmentioning
confidence: 99%
“…Despite legitimate concerns about the adequacy of genome coverage by GBS-like methods for certain questions and in some systems (Lowry et al ., 2016), for many applications in population genomics GBS-like methods are likely to remain attractive for some time (McKinney, 2016). Whereas several studies have examined the consequences of laboratory and bioinformatic methods for variant identification and other downstream analyses (Shafer et al ., 2017; Flanagan & Jones, 2018; Warmuth & Ellegren, 2019), and others have suggested methods to optimize assembly parameters (Puritz et al ., 2014; Paris et al ., 2017), this investigation fills a gap in knowledge regarding the performance of de novo assembly software without the aid of additional steps.…”
Section: Discussionmentioning
confidence: 99%
“…But for RRS methods, many differences between techniques are minor, often implementing streamlined library preparation and cost reduction (e.g., GGRS (Chen et al., ), ezRAD (Toonen et al., )) or the use of specific restriction enzymes and adaptors designed to optimize sequencing depth, coverage, and multiplexing capacity (e.g., MSG (Andolfatto et al., ); two‐enzyme GBS (Poland et al., ); SLAF‐seq (Sun et al., ); quaddRAD (Franchini et al., )). Thus, many published methods, although prone to distinct biases or technical difficulties and subject to a myriad of downstream bioinformatic considerations (Flanagan & Jones, ; Van Dijk, Jaszczyszyn, & Thermes, ), arguably do not meet proposed criteria for publication with a unique name (e.g., NUAP, ). The recently upheld US KeyGene patent covering these methods also seems to suggest that, from a legal standpoint, they are not significantly different from one another (U.S. Patent 8,815,512 B2).…”
Section: Discussionmentioning
confidence: 99%
“…quaddRAD (Franchini et al, 2017)). Thus, many published methods, although prone to distinct biases or technical difficulties and subject to a myriad of downstream bioinformatic considerations (Flanagan & Jones, 2018;Van Dijk, Jaszczyszyn, & Thermes, 2014), arguably do not meet proposed criteria for publication with a unique name (e.g., NUAP, 2011). The recently upheld US KeyGene patent covering these methods also seems to suggest that, from a legal standpoint, they are not significantly different from one another (U.S. Patent 8,815,512 B2).…”
Section: "What's In a Name?" (Shakespeare 1594-98)mentioning
confidence: 99%